New cancer therapy hunts and destroys deadly tumors in major breakthrough study
Off-the-shelf immune cells track and kill pancreatic tumors in preclinical tests
News
For press inquiries, please contact press@CAImmunologyBond.com
FDA Approves Adding Durvalumab Immunotherapy to Prevent Stomach and Esophageal Cancer Recurrence
A clinical trial led by researchers at Memorial Sloan Kettering Cancer Center (MSK) has demonstrated a powerful new approach to help prevent cancer from coming back after treatment for stomach cancer, cancer of the lower portion of the esophagus, and gastroesophageal junction (GEJ) cancer.
Therapy reawakens immune system to fight pancreatic cancer
Antibody unmasks pancreatic tumors’ ‘sugar-coated’ disguise to keep them from evading immune system
Immune system breakthrough wins Nobel medicine prize for US, Japan scientists
American scientists Mary Brunkow and Fred Ramsdell and Shimon Sakaguchi from Japan won the 2025 Nobel Prize in Physiology or Medicine on Monday for work shedding light on how the immune system spares healthy cells, creating openings for possible new autoimmune disease and cancer treatments.
Experimental cancer drugs found to help some patients avoid surgery
Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, chemotherapy or radiation, the Memorial Sloan Kettering study found.
Medicine Spares Cancer Patients From Grisly Surgeries and Harsh Therapies
For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offered stunning results.